These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 310374)

  • 61. Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases.
    Haynes BF; Warren RW; Buckley RH; McClure JE; Goldstein AL; Henderson FW; Hensley LL; Eisenbarth GS
    Birth Defects Orig Artic Ser; 1983; 19(3):255-8. PubMed ID: 6606445
    [No Abstract]   [Full Text] [Related]  

  • 62. The reconstitution of cellular immunity after bone marrow transplantation in children.
    Lanfranchi A; Porta F; Locatelli F; Zecca M; Nespoli L; Albertini A
    Haematologica; 1992; 77(4):336-47. PubMed ID: 1427444
    [No Abstract]   [Full Text] [Related]  

  • 63. Immunologic assessment of the immunodeficient.
    Hong R
    J Allergy Clin Immunol; 1977 Jul; 60(1):83-8. PubMed ID: 326851
    [No Abstract]   [Full Text] [Related]  

  • 64. Proceedings: Infantile partial thymic deficiency: correction of some in vitro T functions by thymus humoral factor.
    Handzel ZT; Levin S; Hahn T; Altman Y; Ashkenazi A; Trainin N; Schechter B
    Isr J Med Sci; 1975 Dec; 11(12):1391. PubMed ID: 1082883
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunological and clinical investigation of a bovine thymic extract. I. "In vitro" effect on T-cell differentiation in normal and pathological conditions.
    Fiorilli M; Ammirati P; Pandolfi F; Sirianni MC; Aiuti F
    Ann Sclavo; 1979; 21(4):494-501. PubMed ID: 317988
    [No Abstract]   [Full Text] [Related]  

  • 66. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A lymphoproliferative syndrome, "cutaneous dystrophy" and combined immune deficiency with lack of helper T-cell factor.
    Wyss M; von Fliedner V; Jacot-Des-Combes E; Jeannet M; Despont JP; Kapanci Y; Cox JN
    Clin Immunol Immunopathol; 1982 Apr; 23(1):34-49. PubMed ID: 6807591
    [No Abstract]   [Full Text] [Related]  

  • 68. [Severe combined immunologic deficiency. On a case with the presence of circulating lymphocytes (E+)unresponsive to mitogenic stimuli (PHA-) and in mixed culture (MLC-)].
    Nicola P; Tovo PA
    Minerva Pediatr; 1978 May; 30(9):677-80. PubMed ID: 149230
    [No Abstract]   [Full Text] [Related]  

  • 69. The primary immunodeficiency diseases: classification, pathogenesis and treatment.
    Gatti RA; Seligmann M
    Turk J Pediatr; 1973 Oct; 15(4):195-215. PubMed ID: 4600502
    [No Abstract]   [Full Text] [Related]  

  • 70. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease.
    Pross HF; Gupta S; Good RA; Baines MG
    Cell Immunol; 1979 Mar; 43(1):160-75. PubMed ID: 313842
    [No Abstract]   [Full Text] [Related]  

  • 71. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.
    Dorshkind K; Keller GM; Phillips RA; Miller RG; Bosma GC; O'Toole M; Bosma MJ
    J Immunol; 1984 Apr; 132(4):1804-8. PubMed ID: 6607948
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The differentiation and function of human T lymphocytes.
    Reinherz EL; Schlossman SF
    Cell; 1980 Apr; 19(4):821-7. PubMed ID: 6991122
    [No Abstract]   [Full Text] [Related]  

  • 73. Response of lymphocytes to plant lectins. I. A thymic-dependent lymphoid population responsive to pokeweed mitogen.
    Weksler ME; Bodine S; Rommer J
    Immunology; 1974 Feb; 26(2):281-90. PubMed ID: 4546902
    [TBL] [Abstract][Full Text] [Related]  

  • 74. T- and B-lymphocytes in immunological disorders.
    Yata J; Okumura K; Nakagawa T; Sumiya M
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):403-12. PubMed ID: 4377862
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe combined immunodeficiency with T lymphocytes retaining functional activity.
    Fontán G; García Rodriguez MC; Carrasco S; Zabay JM; de la Concha EG
    Clin Immunol Immunopathol; 1988 Mar; 46(3):432-41. PubMed ID: 3257433
    [TBL] [Abstract][Full Text] [Related]  

  • 76. European experience with fetal tissue transplantation in severe combined immunodeficiency (SCID).
    Touraine JL
    Birth Defects Orig Artic Ser; 1983; 19(3):139-42. PubMed ID: 6360231
    [No Abstract]   [Full Text] [Related]  

  • 77. XX T cells and XY B cells in two patients with severe combined immune deficiency.
    Conley ME; Nowell PC; Henle G; Douglas SD
    Clin Immunol Immunopathol; 1984 Apr; 31(1):87-95. PubMed ID: 6607807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defect.
    Virelizier JL; Hamet M; Ballet JJ; Reinert P; Griscelli C
    J Pediatr; 1978 Mar; 92(3):358-62. PubMed ID: 416187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Severe combined immunodeficiency with B lymphocytes and with normal MLC response.
    Seligmann M; Griscelli C; Preud'homme JL; Sasportes M; Herzog C; Brouet JC
    Birth Defects Orig Artic Ser; 1975; 11(1):154-7. PubMed ID: 50093
    [No Abstract]   [Full Text] [Related]  

  • 80. Thymic hypoplasia with severe combined immunodeficiency.
    Martin JP; Aguilar FT
    Ann Allergy; 1977 Sep; 39(3):196-200. PubMed ID: 900591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.